Ignite Creation Date:
2024-05-06 @ 3:53 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04799847
Status:
RECRUITING
Last Update Posted:
2023-02-13
First Post:
2021-03-12
Brief Title:
Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
Sponsor:
LintonPharm CoLtd
Organization:
LintonPharm CoLtd
Organization Data
Organization:
LintonPharm CoLtd
Class:
INDUSTRY
Study ID:
LP0190512
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
LintonPharm CoLtd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None